- Home
- VANI vs FORA Comparison
VANI vs FORA Comparison
Compare VANI & FORA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VANI
- FORA
- Stock Information
- Founded
- VANI 1998
- FORA 2014
- Country
- VANI United States
- FORA United States
- Employees
- VANI N/A
- FORA N/A
- Industry
- VANI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- FORA Computer Software: Prepackaged Software
- Sector
- VANI Health Care
- FORA Technology
- Exchange
- VANI Nasdaq
- FORA Nasdaq
- Market Cap
- VANI 65.2M
- FORA 62.7M
- IPO Year
- VANI 2014
- FORA N/A
- Fundamental
- Price
- VANI $1.02
- FORA $1.97
- Analyst Decision
- VANI Strong Buy
- FORA Strong Buy
- Analyst Count
- VANI 1
- FORA 1
- Target Price
- VANI $4.00
- FORA $5.00
- AVG Volume (30 Days)
- VANI 107.5K
- FORA 8.8K
- Earning Date
- VANI 05-12-2025
- FORA 03-27-2025
- Dividend Yield
- VANI N/A
- FORA N/A
- EPS Growth
- VANI N/A
- FORA N/A
- EPS
- VANI N/A
- FORA N/A
- Revenue
- VANI N/A
- FORA $19,709,723.00
- Revenue This Year
- VANI N/A
- FORA N/A
- Revenue Next Year
- VANI N/A
- FORA $13.59
- P/E Ratio
- VANI N/A
- FORA N/A
- Revenue Growth
- VANI N/A
- FORA N/A
- 52 Week Low
- VANI $1.00
- FORA $1.90
- 52 Week High
- VANI $2.22
- FORA $4.03
- Technical
- Relative Strength Index (RSI)
- VANI 34.58
- FORA 41.22
- Support Level
- VANI $1.06
- FORA $2.05
- Resistance Level
- VANI $1.16
- FORA $2.13
- Average True Range (ATR)
- VANI 0.04
- FORA 0.10
- MACD
- VANI -0.00
- FORA -0.00
- Stochastic Oscillator
- VANI 12.50
- FORA 23.69
About VANI Vivani Medical Inc. (DE)
Vivani Medical Inc is a preclinical-stage biopharmaceutical company. It develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases. It has two reporting segments, the Biopharm Division and the Neuromodulation Division.
About FORA Forian Inc.
Forian Inc provides a suite of Software, data management capabilities, and proprietary data and analytics to optimize and measure operational, clinical, and financial performance for customers within the traditional and emerging life sciences, healthcare payer, and provider segments, as well as cannabis dispensaries, manufacturers, and cultivators.